Analyst
HC Wainwright & Co.
Equibles does not estimate personal net worth.
Brandon Folks is recorded as Analyst at HC Wainwright & Co.. Brandon Folks has spoken on 3 earnings calls and 2 other investor events across 3 companies, most recently for PolyPid Ltd. on August 12, 2026. Those appearances were for PolyPid Ltd. (PYPD), Connect Biopharma Holdings Ltd (CNTB) and Ani Pharmaceuticals Inc (ANIP). The companies whose calls Brandon Folks spoke on are classified in the Healthcare sector.
“Can you just talk about the earlier PDUFA date and what that does in terms of ability to supply the markets? or launch date, you know, you still expect a 1Q launch.”
“And I do want to just delve a little bit deeper into that IV data. Sure. Right.”
“I just want to follow up on an earlier question regarding the description growth we're seeing where we sit versus reported revenue on Cortropin. A few sub-questions here.”
“So, in Part B of the IV study, any color insight into the number of subjects which returned to the ER within 29 days? Granted, these were stable patients, but I think it would just be interesting to sort of see if there's any data there ahead of Seabreeze.”
HC Wainwright & Co.
Analyst
Transcript header (unverified)
PYPD
Biotechnology · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
